Waystar Holding Corp
WAY
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
183.6% upsideUndervalued by 183.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.05 Billion |
|---|---|
| Enterprise Value | $5.58 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.63 |
| Beta | 0.07 |
| Outstanding Shares | 191,868,642 |
Return
| Return on Equity | 3.38% |
|---|---|
| Return on Assets | 2.30% |
| Return on Invested Capital | 4.50% |
Valuation & Multiples
| P/E Ratio | 29.32 |
|---|---|
| PEG | 108.67 |
| Price to Sales | 3.52 |
| Price to Book Ratio | 1.06 |
| Enterprise Value to Revenue | 4.63 |
| Enterprise Value to EBIT | 22.01 |
| Enterprise Value to Net Income | 41 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 123.38% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.53%▼ 105.25% |
|---|---|
| Total Invested | $60.54M▼ 98.77% |
| Investors Holding | 46▼ 274.00% |
ESG Score
No data
About Waystar Holding Corp
Relevant Senate Committees
This is the most critical committee for Waystar as it oversees Medicare and Medicaid, the primary drivers of the healthcare reimbursement ecosystem that Waystar facilitates.
The committee controls the actual cash flow to HHS and CMS, directly influencing the liquidity and spending power of the healthcare providers who pay for Waystar's services.
This committee directly regulates the healthcare industry and the Department of Health and Human Services, impacting the standards and legal environment for healthcare payments.